• 1
    IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J. 1986;293: 65964.
  • 2
    Frame PS, Frame JS. Determinants of cancer screening frequency: the example of screening for cervical cancer. J Am Board Fam Pract. 1998;11: 8795.
  • 3
    Colditz GA, Hoaglin DC, Berkey CS. Cancer incidence and mortality: the priority of screening frequency and population coverage. Milbank Q. 1997;75: 14773.
  • 4
    Fahs MC, Mandelblatt J, Schecter C, Muller C. Cost effectiveness of cervical cancer screening for the elderly. Ann Intern Med. 1992;117: 5207.
  • 5
    American College of Physicians. Guidelines: screening for cervical cancer. In: EddyDM, ed. Common Screening Tests. Philadelphia, Pa: American College of Physicians; 1991: 4134.
  • 6
    Koopmanschap MA, Lubbe KTN, Van Oortmarssen GJ, Van Agt HMA, Van Ballegooijen M, Habbema JDF. Economic aspects of cervical cancer screening. Soc Sci Med. 1990;30: 10817.
  • 7
    American Cancer Society. Summary of Current Guidelines for the Cancer-Related Checkup: Recommendations. Atlanta, Ga: American Cancer Society; 1988.
  • 8
    U.S. Preventive Services Task Force. Screening for cervical cancer. In: Guide to Clinical Preventive Services, 2nd edn. Baltimore, Md: Williams & Wilkins; 1996: 10518.
  • 9
    Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society Guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002;52: 34262.
  • 10
    Anonymous. ACOG committee opinions. Recommendations on frequency of Pap test screening. Number 152, March 1995 Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists. Intl J Gynaecol Obstet. 1995;49:2101.
  • 11
    Parboosingh J. Screening for cervical cancer: Canadian programmatic guidelines. Can Fam Phys. 1999;45: 38393.
  • 12
    Hermens RP, Hak E, Hulscher ME, Mulder J, Braspenning JCC, Grol RPTM. Do general practices adhere to organizational guidelines for effective cervical cancer screening? Fam Pract. 1998;15: 1128.
  • 13
    Bergstrom R, Sparen P, Adami H-O. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer. 1999;81: 15966.
  • 14
    Quinn M, Babb P, Jones J, Allen E, on behalf of the United Kingdom Association of Cancer Registries. Effect of screening on incidence of and mortality from cancer of the cervix in England: evaluation based on routinely collected statistics. Br Med J. 1999;318: 9048.
  • 15
    Wai D, Ferrier A, Collings S, Laverty C. Have the most recent Pap smear guidelines affected GP practices? Austral Fam Phys. 1996;(suppl 1):448.
  • 16
    Mandelblatt JS, Lawrence WF, Womack SM, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA. 2002;287: 237281.
  • 17
    National Center for Health Statistics. Data File Documentation, National Health Interview Survey, 2000 (machine readable data file and documentation). Hyattsville, Md: National Center for Health Statistics; 2002. Available at: Accessed October 30, 2002.
  • 18
    National Center for Health Statistics. Survey Description, National Health Interview Survey, 2000. Hyattsville, Md: National Center for Health Statistics; 2002. Available at: Accessed January 21, 2004.
  • 19
    Sawaya GF, Kerlikowske K, Lee NC, Gildengorin G, Washington AE. Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet Gynecol. 2000;96: 21923.
  • 20
    Sawaya GF, Grady D, Kerlikowske K, et al. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med. 2000;133: 94250.
  • 21
    Incidence of Pap test abnormalities within 3 years of a normal Pap test—United States 1991–1998 (Editorial Note) MMWR Morb Mortal Wkly Rep. 2000;49:10013.
  • 22
    Castleberry BM, Wargelin LL. 1998 Wage and vacancy survey of medical laboratories. Lab Med. 1999;30: 1748.
  • 23
    Pear R. 1988 Standards for medical labs go unenforced by administration. New York Times. March 20, 1991: 1.
  • 24
    Centers for Disease Control. Regulations for implementing Clinical Laboratory Improvement Amendments of 1988: a summary. JAMA. 1992;267: 172534.
  • 25
    Koss LG. The Papanicolaou test for cervical cancer detection: a triumph and a tragedy. JAMA. 1989;261: 73743.
  • 26
    Bell S, Porter M, Kitchener H, Fraser C, Fisher P, Mann E. Psychological response to cervical screening. Prev Med. 1995;24: 6106.
  • 27
    Peters T, Somerset M, Baxter K, Wilkinson C. Anxiety among women with mild dyskaryosis: a randomized trial of an educational intervention. Br J General Pract. 1999;49: 34852.
  • 28
    Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol. 1994;11: 3906.
  • 29
    Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999;91: 2528.
  • 30
    Melnikow J, Nuovo J, Willan AR, Chan BKS, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998;92: 72735.
  • 31
    Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12: 18692.
  • 32
    Kavanagh AM, Santow G, Mitchell H. Consequences of current patterns of Pap smear and colposcopy use. J Med Screen. 1996;3: 2934.
  • 33
    McGovern PG, Lurie N, Margolis KL, Slater JS. Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prev Med. 1998;14: 2018.
  • 34
    Bowman JA, Sanson-Fisher R, Redman S. The accuracy of self-reported Pap smear utilisation. Soc Sci Med. 1997;44: 969–76.
  • 35
    Suarez L, Goldman DA, Weiss NS. Validity of Pap smear and mammogram self-reports in a low-income Hispanic population. Am J Prev Med. 1995;11: 948.
  • 36
    Whitman S, Lacey L, Ansell D, Chen EH, Dell J, Phillips CW. Do chart reviews and interviews provide the same information about breast and cervical cancer screening? Int J Epidemiol. 1993;22: 3937.
  • 37
    McKenna MT, Speers M, Malin K, Warnecke R. Agreement between patient self-reports and medical records for Pap smear histories. Am J Prev Med. 1992;8: 28791.
  • 38
    Bowman JA, Redman S, Dickinson JA, Gibberd R, Sanson-Fisher RW. The accuracy of Pap smear utilization self-report: a methodological consideration in cervical screening research. Health Serv Res. 1991;26: 97107.
  • 39
    Herman CJ, Lengerich EJ, Stoodt G. Variation in recommendation for breast and cervical cancer screening among primary care physicians in North Carolina, 1991. South Med J. 1996;89: 58390.
  • 40
    Rolnick SJ, LaFerla JJ, Jackson J, Akkerman D, Compo R. Impact of a new cervical Pap smear screening guideline on member perceptions and comfort levels. Prev Med. 1999;28: 5304.
  • 41
    Lawson HW, Henson R, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR Morb Mortal Wkly Rep. 2000;49: 3655.
  • 42
    Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132: 8109.